Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
104.00Prev. Close
104.25Volume
31,032Total traded value
0.33 CrUpper Circuit
125.10Lower Circuit
83.40Fundamentals
| Market Cap | ₹964Cr |
| ROE | -7.10% |
| P/E Ratio(TTM) | -35.73 |
| EPS(TTM) | -2.93 |
| P/B Ratio | 2.78 |
| Dividend Yield | 0.48% |
| Industry P/E | 33.35 |
| Book Value | 37.70 |
| Debt to Equity | 0.25 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Themis Medicare
Themis Medicare is a pharmaceutical company engaged in manufacturing formulations and Active Pharmaceutical Ingredients (APIs). Throughout the year, the company upheld the highest standards of integrity, transparency, and ethical conduct in all its business operations. Demonstrating its commitment to global growth, it has filed more than 75 product registration dossiers for formulations in international markets.;
| Parent Organisation | Themis Medicare |
| Managing Director | Dr. Sachin Patel |
| NSE Symbol | THEMISMED |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.48 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.22 | ||
| Wockhardt | NA (0.00%) | -450.68 | ||
| Cohance Lifesciences | NA (0.00%) | 66.37 |